Outcome | Baseline | 3Â weeks | 12Â weeks/3Â months | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Feedback | No Feedback | Feedback | No feedback | Feedback | No feedback | |||||||
M (SD) | Median (range) | M (SD) | Median (range) | M (SD) | Median (range) | M (SD) | Median (range) | M (SD) | Median (range) | M (SD) | Median (range) | |
Performance-based | ||||||||||||
 Grip strength (Kg) | ||||||||||||
  Right | 21 (13.2) |  | 24 (13.1) |  | 20 (13.7) |  | 25 (13.6) |  |  |  |  |  |
  Left | 19 (11.7) |  | 17 (11.2) |  | 23 (9.3) |  | 15 (10.1) |  |  |  |  |  |
 10-m walk test (s) | 43 (31.8) |  | 40 (32.3) |  | 37 (34.5) |  | 48 (41.8) |  |  |  |  |  |
 MoCA | 17 (5.6) | 18 (9–28) | 17 (6.4) | 21 (7–26) | 19 (7.4) | 22 (6–28) | 18 (6.4) | 21 (7–26) |  |  |  |  |
 BI | 9 (4.0) | 8 (5–18) | 11 (4.2) | 11 (5–21) | 12 (3.7) | 12 (6–19) | 12 (4.4) | 13 (7–20) |  |  |  |  |
Self-report | ||||||||||||
 FSS |  | 39 (9–50) |  | 48 (9–60) |  | 40 (33–55) |  | 52 (20–63) |  |  |  |  |
 VAF-S |  | 6 (0–10) |  | 8 (0–10) |  | 5 (3–10) |  | 7 (5–10) |  |  |  |  |
 EQ-5D-5L VAS | 47.9 (24.9) | 52 (10–90) | 55 (29.6) | 60 (0–100) | 52 (24.5) | 57 (0–80) | 61 (26.0) | 70 (20–100) | 55 (24.2) | 50 (30–90) | 60 (10.2) | 60 (50–75) |
 RMI |  | 4 (1–13) |  | 6 (2–15) |  | 8 (1–14) |  | 6 (3–15) |  | 8 (3–15) |  | 9 (0–14) |
 WHODAS |  | 48 (12–85) |  | 54 (16–87) |  | 46 (4–79) |  | 44 (20–95) |  | 39 (2–60) |  | 45 (4–79) |